Abstract:To develop matrix metalloproteinase inhibitors (MMPIs) for both therapy and medicinal imaging by fluorescence-based techniques or positron-emission tomography (PET), a small library of eighteen N-substituted N-arylsulfonamido d-valines were synthesized and their potency to inhibit two gelatinases (MMP-2, and MMP-9), two collagenases (MMP-8, and MMP-13) and macrophage elastase (MMP-12) was determined in a Structure-Activity-Relation study with ({4-[3-(5-methylthiophen-2-yl)-1,2,4-oxadiazol-5-yl]phenyl}sulfonyl)-d-valine (1) as a lead. All compounds were shown to be more potent MMP-2/-9 inhibitors (nanomolar range) compared to other tested MMPs. This is a remarkable result considering that a carboxylic acid group is the zinc binding moiety. The compound with a terminal fluoropropyltriazole group at the furan ring (P1' substituent) was only four times less potent in inhibiting MMP-2 activity than the lead compound 1, making this compound a promising probe for PET application (after using a prosthetic group approach to introduce fluorine-18). Compounds with a TEG spacer and a terminal azide or even a fluorescein moiety at the sulfonylamide N atom (P2' substituent) were almost as active as the lead structure 1, making the latter derivative a suitable fluorescence imaging tool.

Synthesis of New Sulfonyl Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors

Design, Synthesis and Preliminary Evaluation of Novel Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors

Design, Synthesis, and Primary Activity Evaluation of Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors.

Sulfonyl Phosphonic 1,4-Dithia-7-azaspiro[4,4]nonane Derivatives As Matrix Metalloproteinase Inhibitors: Synthesis, a Docking Study, and Biological Evaluation.

Design, Synthesis, and Biological Evaluation of 4-Phenoxybenzenesulfonyl Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors

Design, Synthesis and Preliminary Evaluation of Α-Sulfonyl Γ-(Glycinyl-amino)proline Peptidomimetics As Matrix Metalloproteinase Inhibitors.

Synthesis and Characterization of Pyrrolidine Derivatives As Matrix Metalloproteinase-2 Inhibitors

[Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].

Advances in Matrix Metalloproteinase Inhibitors Based on Pyrrolidine Scaffold

Sulfonamide Derivatives Containing Dihydropyrazole Moieties Selectively and Potently Inhibit Mmp-2/Mmp-9: Design, Synthesis, Inhibitory Activity and 3D-Qsar Analysis

Synthesis and Gelatinase (MMP-2, MMP-9) Inhibitory Activities of Pyrrolidine Derivatives

Protein Catabolic Enzymes Inhibitory Activities of Pyrrolidine Derivatives

Design, Synthesis and Preliminary Evaluation of New Cinnamoyl Pyrrolidine Derivatives As Potent Gelatinase Inhibitors

Synthesis and Biological Evaluation of Novel Benzofuroxan-Based Pyrrolidine Hydroxamates As Matrix Metalloproteinase Inhibitors with Nitric Oxide Releasing Activity.

3D-QSAR study of pyrrolidine derivatives as matrix metalloproteinase-2 inhibitors

Design, Synthesis, Evaluation and 3D-QSAR Analysis of Benzosulfonamide Benzenesulfonates As Potent and Selective Inhibitors of MMP-2

The Synthesis and Preliminary Activity Assay in Vitro of Peptide-Like Derivatives As APN Inhibitors

Influence of N-arylsulfonamido d-valine N-substituents on the selectivity and potency of matrix metalloproteinase inhibitors

Synthesis of Derivatives of Methyl Rosmarinate and Their Inhibitory Activities Against Matrix Metalloproteinase-1 (MMP-1)

Design, synthesis and preliminary bioactivity evaluations of 8-hydroxyquinoline derivatives as matrix metalloproteinase (MMP) inhibitors.

Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).